News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Yurasov Sergey
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2021 |
4
| Yurasov Sergey (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 398,935 options to buy
@ $4.6, valued at
$1.8M
Granted 398,935 options to buy
@ $1.74, valued at
$694.1k
|
|
| 02/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2019 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 6,136 shares
@ $5.85, valued at
$35.9k
Disposed/sold 72,620 restricted stock units
@ $0
Disposed/sold 110,000 options to buy
@ $4.05, valued at
$445.5k
Disposed/sold 113,335 options to buy
@ $4.4, valued at
$498.7k
Disposed/sold 110,000 options to buy
@ $1.31, valued at
$144.1k
|
|
| 01/07/2019 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 25,000 shares
@ $0
Sold 3,522 shares
@ $1.5717, valued at
$5.5k
Granted 110,000 options to buy
@ $1.31, valued at
$144.1k
|
|
| 11/09/2018 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 29,953 shares
@ $0 |
|
| 07/19/2018 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 52,768 options to buy
@ $7.58, valued at
$400k
Granted 35,179 options to buy
@ $4.4, valued at
$154.8k
Disposed/sold 87,232 options to buy
@ $7.58, valued at
$661.2k
Granted 58,155 options to buy
@ $4.4, valued at
$255.9k
Disposed/sold 625 options to buy
@ $5.6, valued at
$3.5k
Granted 417 options to buy
@ $4.4, valued at
$1.8k
Disposed/sold 29,375 options to buy
@ $5.6, valued at
$164.5k
Granted 19,584 options to buy
@ $4.4, valued at
$86.2k
|
|
| 01/08/2018 |
4/A
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 675 shares
@ $4.1725, valued at
$2.8k
|
|
| 01/05/2018 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 22,000 shares
@ $0
Sold 675 shares
@ $4.1725, valued at
$2.8k
Granted 110,000 options to buy
@ $4.05, valued at
$445.5k
|
|
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|